May 18 (Bloomberg) -- Jeffrey Kraws, Senior Research Analyst and Cofounder of Crystal Research Associates, appeared Monday, May 18, 2009, on Bloomberg Television discussing drug companies that are well positioned to develop a vaccine against the H1N1 influenza (swine flu). Companies addressed included Sanofi-aventis SA (SNY-NYSE), GlaxoSmithKline plc (GSK-NYSE), Novartis AG (NVS-NYSE), and Unilife Medical Solutions Ltd. (UNI-ASX).
Link to this comment:
All Comments (0)